Recent
price
P/E
ratio
div
yld
0.14%
ROIC.AI
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Merck Ends Keytruda Combo Melanoma Study Due to Futility
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next
Analysts Offer Insights on Healthcare Companies: ANI Pharmaceuticals (ANIP), Fate Therapeutics (FATE) and Instil Bio (TIL)
ANI Pharmaceuticals Inc (ANIP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
ANI Pharmaceuticals Inc (ANIP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Expansions
Q1 2024 ANI Pharmaceuticals Inc Earnings Call Transcript
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript
ANI Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
ANI Pharmaceuticals Reports Strong Q1 2024 Results, Surpassing Revenue Expectations
ANI Pharmaceuticals Reports Strong Q1 2024 Results, Surpassing Revenue Expectations
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.